Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Leukemia - United Kingdom
doi 10.1038/s41375-019-0507-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Pathways in Chronic Lymphocytic Leukemia: Challenges and Solutions

American Journal of Hematology
Hematology
2016English

Targeting Inflammatory Pathways for Tumor Radiosensitization

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia

Turkish Journal of Haematology
Hematology
2016English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Inflammation and Survival Pathways: Chronic Lymphocytic Leukemia as a Model System

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy